The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Apiam Animal Health (AHX) launches an entitlement offer to raise up to $20.25 million for its accelerated acquisition strategy and debt repayment
  • Eligible shareholders will be able to subscribe for one new shares for every 4.8 held at a price of 70 cents each
  • This represents a 9.1 per cent discount from the last closing price and a 10.6 per cent discount from the five-day volume-weighted average price
  • The money raised will help fund the acquisitions of two high growth Victorian veterinary clinics
  • Shares close flat to trade at 77 cents

Apiam Animal Health (AHX) has launched an entitlement offer to raise up to $20.25 million for its accelerated acquisition strategy and debt repayment.

Eligible shareholders will be able to subscribe for one new share for every 4.8 held at a price of 70 cents each.

This represents a 9.1 per cent discount from the last closing price and a 10.6 per cent discount from the five-day volume-weighted average price.

The money raised will help fund the acquisitions of two high growth Victorian veterinary clinics.

Managing Director Dr Chris Richards said he plans to take up about $4.5 million under the offer.

“Funds raised from the entitlement offer will support us to pursue our strategy to double our revenue base to more than $300 million by FY24 and execute on the next phase of growth opportunities we have identified,” he said.

The offer will open on June 2 and will be fully underwritten.

Shares closed flat to trade at 77 cents.

AHX by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX steams uphill but still on track to recovery

The ASX200 closed .4 of a per cent up with IT and Health Care the locomotives…
The Market Online Video

Market Update: ASX edges up with a healthier disposition

The ASX200 is trading up around half a per cent with Health Care and Real Estate…
Magnetite

Fe grades above 71% make Cyclone Metals bullish about Iron Bear pilot plant

Cyclone Metals, an iron ore developer which has built its business progressing Canadian magnetite play Iron…

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…